Form 4: Jazz Pharmaceuticals Executive Renee D Gala Reports Share Transactions Following Vesting of Performance Awards
SEC Form 4
Jazz Pharmaceuticals' President & COO, Renee D Gala, acquired shares through performance award vesting and sold some to cover tax obligations.
Summary
- Renee D Gala, President & COO of Jazz Pharmaceuticals, acquired 7,741 ordinary shares on January 17, 2025, as part of a performance share award granted on March 3, 2022.
- The performance-based vesting requirements for these awards were met on January 17, 2025.
- To cover tax obligations, 3,300 shares were withheld at a price of $122.62 per share.
- Following these transactions, Ms. Gala beneficially owns 59,933 ordinary shares.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, indicating that performance goals were met. There are no negative implications, and the executive's continued ownership is a positive sign.
Positives
- The vesting of performance awards indicates that performance goals were met, which is a positive sign for the company.
- The executive's continued ownership of a significant number of shares aligns her interests with those of the shareholders.
Industry Context
This is a standard transaction related to executive compensation in publicly traded companies, where performance-based equity awards are common.
Comparison to Industry Standards
- The vesting of performance-based equity awards is a common practice among publicly traded companies, including those in the pharmaceutical sector such as AbbVie, Amgen, and Gilead Sciences.
- These companies also use similar vesting schedules and tax withholding mechanisms for their executive compensation packages.
- The share price of $122.62 is within the range of recent trading activity for Jazz Pharmaceuticals, indicating a fair market value for the transaction.
Stakeholder Impact
- The transaction has a neutral impact on shareholders, as it is a standard part of executive compensation.
- The vesting of performance awards may positively impact employee morale, as it indicates that performance goals are being met.
Key Dates
| Date | Description |
|---|---|
| 03/03/2022 | Date of the performance share awards granted to Renee D Gala. |
| 01/17/2025 | Date the performance-based vesting requirements were satisfied and shares were acquired and sold for tax obligations. |
| 01/22/2025 | Date the Form 4 was signed. |
Keywords
Jazz Pharmaceuticals, Renee D Gala, performance share awards, share vesting, executive compensation, insider trading, tax obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.